Drug use and HIV infection status of detainees in re-education through labour camps in Guangxi Province, China
|dc.identifier.citation||Zhang, L. and Yap, L. and Reekie, J. and Liu, W. and Chen, Y. and Wu, Z. and Wand, H. et al. 2015. Drug use and HIV infection status of detainees in re-education through labour camps in Guangxi Province, China. International Journal of Environmental Research and Public Health. 12 (5): pp. 4502-4519.|
This study describes HIV disease burden and patterns of drug use before and during incarceration among detainees in Re-education-Through-Labour-Camps (RTLCs) in China. A cross-sectional survey of 576 men and 179 women from three RTLCs was conducted in Guangxi Province, China. Over three-quarters of study participants were detained due to drug-related offences. Over half of the women (n = 313, 54.3%) and twothirds of men (n = 119, 66.5%) had been previously been incarcerated in a compulsory detoxification treatment centre (CDTC), and around one-third (men n = 159, 27.6%; women n = 50, 27.9%) in a RTLC. Of those surveyed, 49 men (8.5%) and one (0.6%) woman reported ever using drugs while in a CDTC and/or RTLC. Previous incarceration in CDTCs and RTLCs were associated with HIV infection among both male (OR = 2.15 [1.11–4.15]) and female (OR = 3.87 [1.86–9.04]) detainees. Being married/cohabiting with a partner (OR = 0.53, [0.30–0.93]) and being employed (OR = 0.46, [0.22–0.95]) were associated with a reduced odds of HIV infection among male detainees. A significant proportion of RTLC detainees had a history of drug use and a limited number of inmates had used illegal substances whilst in custody. Repeat incarcerations in CDTCs/RTLCs were associated with higher risks of HIV infection.
|dc.title||Drug use and HIV infection status of detainees in re-education through labour camps in Guangxi Province, China|
|dcterms.source.title||International Journal of Environmental Research and Public Health|
This open access article is distributed under the Creative Commons license
|curtin.department||National Drug Research Institute (NDRI)|